Ambergen, Inc.
WATERTOWN, MA · Founded 2022 · CIK 0001923459 · Medtech · Private
Photocleavable mass-tag reagents and imaging system for multiplexed mass spectrometry imaging of biological tissues
ambergen.com →- Grants
- $22M
- 20 awards
- Sector median: 1
- Raised
- $5.0M
- 1 Form D · Apr 2022
- 53 months since last filing
- Contracts
- $200K
- 1 award · Health and Human S
- #458 of 4531 in medtech
- Patents
- 25
- 11 granted · 14 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2012201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Health and Human Services · Igf::ot::igf Other Functions "phase I, Topic 309, Label-free Multivariate Cancer Diagnosis" | $199,767 | |
| Federal grant | Department of Health and Human Services · Phase II · Multiplexed Bead-based In Vitro Pediatric Allergy Test | $998,905 | |
| Federal grant | Department of Health and Human Services · Phase II · Global Proteomic Screening by MALDI Spectrometric Imaging of Protein-Bead Arrays | $499,744 | |
| Federal grant | Department of Health and Human Services · Phase II · Multiplexed Bead-based In Vitro Pediatric Allergy Test | $998,905 | |
| Federal grant | Department of Health and Human Services · Phase I · Photocleavage Technology for Improved Serum-based Multi-Biomarker Cancer Assays | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Mass Spectrometric Bead-Imaging of Off-Target Drug Interactions | $753,500 | |
| Federal grant | Department of Health and Human Services · Phase II · Mass Spectrometric Bead-Imaging of Off-Target Drug Interactions | $753,500 | |
| Federal grant | Department of Health and Human Services · Phase II · Multiplexed Bead-based In Vitro Pediatric Allergy Test | $1,937,987 | |
| Federal grant | Department of Health and Human Services · Phase II · Mass Spectrometric Bead-Imaging of Off-Target Drug Interactions | $753,500 | |
| Federal grant | Department of Health and Human Services · Phase I · Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Multiplexed Bead-based In Vitro Pediatric Allergy Test | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues | $999,744 | |
| Federal grant | Department of Health and Human Services · Phase II · Photocleavage Technology for Blood-based Multi-Biomarker Alzheimer's Disease Assay | $2,499,916 | |
| Federal grant | Department of Health and Human Services · Phase II · Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues | $999,744 | |
| Federal grant | Department of Health and Human Services · Phase II · Photocleavage Technology for Blood-based Multi-Biomarker Alzheimer's Disease Assay | $1,249,958 | |
| Private capital raised | Form D · SEC | $5,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · New Technology for High-Resolution Antibody Profiling for SARS-CoV-2 | $1,957,250 | |
| Federal grant | Department of Health and Human Services · Phase II · Photocleavable Mass-Tags for Spatial Multiomics of Alzheimer’s Brain Tissue | $2,435,984 | |
| Federal grant | Department of Health and Human Services · Phase II · A Highly Multiplexed, Multiomic 3D Mouse Brain Map Using MALDI-IHC | $1,084,108 | |
| Federal grant | Department of Health and Human Services · Phase II · A Highly Multiplexed, Multiomic 3D Mouse Brain Map Using MALDI-IHC | $910,446 | |
| Federal grant | Department of Health and Human Services · Phase II · New Technology for High-Resolution Antibody Profiling for SARS-CoV-2 | $978,625 | |
| Federal grant | Department of Health and Human Services · Phase II · Photocleavable Mass-Tags for Spatial Multiomics of Alzheimer’s Brain Tissue | $1,081,032 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 455 | INVENIO IMAGING INC | $206K | $7.5M |
| 456 | PRESSURE PROFILE SYSTEMS, INC. | $203K | — |
| 457 | NANOMATERIAL INNOVATION LTD | $200K | — |
| 458 | Ambergen, Inc. | $200K | $5.0M |
| 459 | KINETIC RIVER CORP. | $195K | — |
| 460 | Aseko, Inc. | $191K | $63M |
| 461 | REDLEN TECHNOLOGIES INC | $191K | $2.7M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Michael EasterlingDirector
- Peter FinnExecutive Officer
- John GillespieDirector · Executive Officer
- Brian RothschildDirector
- Kenneth RothschildDirector · Executive Officer
Patents
- Photocleavable Mass-tags For Multiplexed Mass Spectrometric Imaging Of Tissues Using Biomolecular Probesgranted
- Novel Photocleavable Mass-tags For Multiplexed Mass Spectrometric Imaging Of Tissues Using Biomolecular Probesapplication
- Photocleavable Mass-tags For Multiplexed Mass Spectrometric Imaging Of Tissues Using Biomolecular Probesapplication
- Novel Photocleavable Mass-tags For Multiplexed Mass Spectrometric Imaging Of Tissues Using Biomolecular Probesgranted
- Photocleavable Mass-tags For Multiplexed Mass Spectrometric Imaging Of Tissues Using Biomolecular Probesgranted
- Novel Photocleavable Mass-tags For Multiplexed Mass Spectrometric Imaging Of Tissues Using Biomolecular Probesgranted
- Novel Photocleavable Mass-Tags for Multiplexed Mass Spectrometric Imaging of Tissues Using Biomolecular Probesapplication
- Novel Photocleavable Mass-tags For Multiplexed Mass Spectrometric Imaging Of Tissues Using Biomolecular Probesgranted
- Global Proteomic Screening Of Random Bead Arrays Using Mass Spectrometry Imaginggranted
- Novel Photocleavable Mass-tags For Multiplexed Mass Spectrometric Imaging Of Tissues Using Biomolecular Probesgranted
- Novel Photocleavable Mass-Tags for Multiplexed Mass Spectrometric Imaging of Tissues Using Biomolecular Probesapplication
- Global Proteomic Screening Of Random Bead Arrays Using Mass Spectrometry Imagingapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.